Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Hematopoietic cell lineage	15/99	2.6052734366890546E-9	6.056881061298864E-7	0	0	8.510303877052044	168.21235334300542	MME;IL11RA;FLT3;ITGA3;FLT3LG;CD3E;CD3D;HLA-DMA;HLA-DPB1;HLA-DRA;CD36;HLA-DOA;HLA-DRB1;HLA-DPA1;HLA-DQB1
Allograft rejection	10/38	4.588546258559745E-9	6.056881061298864E-7	0	0	16.86335403726708	323.7713820556929	HLA-DMA;HLA-B;HLA-DPB1;HLA-DRA;HLA-A;HLA-DOA;HLA-F;HLA-DRB1;HLA-DPA1;HLA-DQB1
Graft-versus-host disease	10/42	1.3240678554641881E-8	1.1173474401312838E-6	0	0	14.752415458937199	267.60840390923136	HLA-DMA;HLA-B;HLA-DPB1;HLA-DRA;HLA-A;HLA-DOA;HLA-F;HLA-DRB1;HLA-DPA1;HLA-DQB1
Type I diabetes mellitus	10/43	1.6929506668655814E-8	1.1173474401312838E-6	0	0	14.304640608988436	255.97021128551876	HLA-DMA;HLA-B;HLA-DPB1;HLA-DRA;HLA-A;HLA-DOA;HLA-F;HLA-DRB1;HLA-DPA1;HLA-DQB1
Th1 and Th2 cell differentiation	13/92	7.116430220887108E-8	3.757475156628393E-6	0	0	7.806245957682712	128.47733892445515	NOTCH3;CD3E;CD3D;ZAP70;HLA-DMA;LCK;HLA-DPB1;HLA-DRA;HLA-DOA;JAK3;HLA-DRB1;HLA-DPA1;HLA-DQB1
Antigen processing and presentation	12/78	8.664119771992967E-8	3.8122126996769057E-6	0	0	8.609885260370698	140.00956659487366	HLA-DMA;CTSL;HLA-B;HLA-DPB1;HLA-DRA;HLA-A;HLA-DOA;HLA-F;HLA-DRB1;CTSB;HLA-DPA1;HLA-DQB1
Autoimmune thyroid disease	10/53	1.4249940532438916E-7	5.104208351593689E-6	0	0	10.972362655881362	172.96753501140944	HLA-DMA;HLA-B;HLA-DPB1;HLA-DRA;HLA-A;HLA-DOA;HLA-F;HLA-DRB1;HLA-DPA1;HLA-DQB1
Phagosome	16/152	1.5467298035132391E-7	5.104208351593689E-6	0	0	5.6055363321799305	87.90575591638326	MSR1;SFTPD;HLA-B;HLA-A;HLA-F;HLA-DMA;FCGR3B;CLEC7A;CTSL;HLA-DPB1;HLA-DRA;CD36;HLA-DOA;HLA-DRB1;HLA-DPA1;HLA-DQB1
Asthma	8/31	1.964812708220083E-7	5.7634506107789105E-6	0	0	16.348662207357858	252.46746500969664	HLA-DMA;HLA-DPB1;HLA-DRA;HLA-DOA;MS4A2;HLA-DRB1;HLA-DPA1;HLA-DQB1
Th17 cell differentiation	13/107	4.330695167649371E-7	1.1433035242594339E-5	0	0	6.555521043640317	96.05390397725526	CD3E;CD3D;RXRB;ZAP70;HLA-DMA;LCK;HLA-DPB1;HLA-DRA;HLA-DOA;JAK3;HLA-DRB1;HLA-DPA1;HLA-DQB1
Viral myocarditis	10/60	4.827206283796729E-7	1.158529508111215E-5	0	0	9.432850241545895	137.1897491969253	HLA-DMA;HLA-B;HLA-DPB1;HLA-DRA;HLA-A;HLA-DOA;HLA-F;HLA-DRB1;HLA-DPA1;HLA-DQB1
Human T-cell leukemia virus 1 infection	18/219	1.0817901994908305E-6	2.379938438879827E-5	0	0	4.273582824792295	58.705751260048956	CDKN2B;ATF6B;HLA-B;HLA-A;HLA-F;CD3E;CD3D;HLA-DMA;CCND2;LCK;CDK2;HLA-DPB1;HLA-DRA;HLA-DOA;JAK3;HLA-DRB1;HLA-DPA1;HLA-DQB1
Epstein-Barr virus infection	17/202	1.5535376689935714E-6	3.1548764970330987E-5	0	0	4.378072913208048	58.55661953003403	LYN;HLA-B;HLA-A;HLA-F;CD3E;CD3D;HLA-DMA;CCND2;IRF3;CDK2;HLA-DPB1;HLA-DRA;HLA-DOA;JAK3;HLA-DRB1;HLA-DPA1;HLA-DQB1
Cell adhesion molecules	14/148	3.3333288175207247E-6	6.285705770181938E-5	0	0	4.954277393520204	62.48106310215804	HLA-B;HLA-A;F11R;HLA-F;VCAN;HLA-DMA;CLDN15;CD6;HLA-DPB1;HLA-DRA;HLA-DOA;HLA-DRB1;HLA-DPA1;HLA-DQB1
Staphylococcus aureus infection	11/95	5.3946840046209855E-6	9.494643848132935E-5	0	0	6.180445059379684	74.9693951863478	HLA-DMA;FCGR3B;DEFA4;HLA-DPB1;DEFA3;HLA-DRA;DEFA1;HLA-DOA;HLA-DRB1;HLA-DPA1;HLA-DQB1
Intestinal immune network for IgA production	7/48	6.367936688069456E-5	0.0010507095535314604	0	0	7.998186816400538	77.27568132417294	HLA-DMA;HLA-DPB1;HLA-DRA;HLA-DOA;HLA-DRB1;HLA-DPA1;HLA-DQB1
Rheumatoid arthritis	9/93	1.5865828463242277E-4	0.002463869831938801	0	0	5.032358003442341	44.026881444428795	HLA-DMA;CTSL;HLA-DPB1;HLA-DRA;HLA-DOA;CXCL5;HLA-DRB1;HLA-DPA1;HLA-DQB1
Leishmaniasis	8/77	2.2390605518427922E-4	0.003283955476036095	0	0	5.4367335562987735	45.691852788247026	HLA-DMA;FCGR3B;HLA-DPB1;HLA-DRA;HLA-DOA;HLA-DRB1;HLA-DPA1;HLA-DQB1
Inflammatory bowel disease	7/65	4.421383106154256E-4	0.006143395473814334	0	0	5.648970478789383	43.6320141913129	HLA-DMA;HLA-DPB1;HLA-DRA;HLA-DOA;HLA-DRB1;HLA-DPA1;HLA-DQB1
Toxoplasmosis	9/112	6.371762857939444E-4	0.008410726972480066	0	0	4.100058486372675	30.170133577124474	HLA-DMA;PDPK1;ALOX5;HLA-DPB1;HLA-DRA;HLA-DOA;HLA-DRB1;HLA-DPA1;HLA-DQB1
Primary immunodeficiency	5/38	0.0011796580571873945	0.01482998700464153	0	0	7.066970420192377	47.64926476357303	ZAP70;LCK;CD3E;CD3D;JAK3
Tuberculosis	10/180	0.005179100320156394	0.062149203841876735	0	0	2.757317419721512	14.512103269975563	HLA-DMA;FCGR3B;ARHGEF12;CLEC7A;HLA-DPB1;HLA-DRA;HLA-DOA;HLA-DRB1;HLA-DPA1;HLA-DQB1
Axon guidance	10/182	0.00559023226927863	0.06416614430824166	0	0	2.7249747219413547	14.133720243391608	PARD6B;ARHGEF12;ABLIM3;PDPK1;TRPC1;LIMK2;PLXNC1;EPHB2;MYL9;SSH1
Transcriptional misregulation in cancer	10/192	0.008042287429711957	0.0830800950423924	0	0	2.5739236608801828	12.414141226445821	RXRB;SMAD1;CCND2;PAX8;FLT3;DEFA4;COMMD3-BMI1;DEFA3;DEFA1;BAIAP3
Insulin resistance	7/108	0.008171519461779023	0.0830800950423924	0	0	3.2368164874041363	15.559701853235644	SREBF1;CPT1A;PDPK1;PPP1R3E;INSR;CD36;CPT1B
Systemic lupus erythematosus	8/135	0.008182130572356828	0.0830800950423924	0	0	2.9450333131435493	14.15324905117388	HLA-DMA;FCGR3B;HLA-DPB1;HLA-DRA;HLA-DOA;HLA-DRB1;HLA-DPA1;HLA-DQB1
PI3K-Akt signaling pathway	15/354	0.008932204612947995	0.08733711177104707	0	0	2.0811606118960557	9.819107311564444	TNXB;ATF6B;FLT3;ITGA3;PDPK1;INSR;VEGFB;FLT3LG;CCND2;COL6A2;COL4A3;CDK2;GNB4;PIK3AP1;JAK3
Viral carcinogenesis	10/203	0.01161700453755286	0.10953175706835554	0	0	2.425846662161147	10.807839085217704	LYN;CDKN2B;CCND2;IRF3;ATF6B;CDK2;HLA-B;HLA-A;HLA-F;JAK3
Small cell lung cancer	6/92	0.01353976373198802	0.12325853880154612	0	0	3.2530321575609213	13.994949218379357	RXRB;CDKN2B;ITGA3;COL4A3;CDK2;FHIT
Fc epsilon RI signaling pathway	5/68	0.014630644589396542	0.12874967238668958	0	0	3.6960639466606056	15.61452852373863	LYN;PDPK1;PLA2G4B;ALOX5;MS4A2
Human immunodeficiency virus 1 infection	10/212	0.015344087220555146	0.13067222665246964	0	0	2.316688190558186	9.676864666426455	IRF3;GNAQ;LIMK2;HLA-B;GNB4;HLA-A;HLA-F;CD3E;CD3D;APOBEC3A
PPAR signaling pathway	5/74	0.020416911973851933	0.16843952378427846	0	0	3.37362941440974	13.12811351308023	RXRB;CPT1A;PDPK1;CD36;CPT1B
Ovarian steroidogenesis	4/51	0.02274515919645766	0.18196127357166128	0	0	3.9572441742654507	14.971849238464653	PLA2G4B;ALOX5;INSR;CYP1B1
Focal adhesion	9/201	0.027993234462466134	0.21735923229679585	0	0	2.189457831325301	7.829046726673163	TNXB;CCND2;ITGA3;PDPK1;COL6A2;COL4A3;VEGFB;MYL9;DOCK1
B cell receptor signaling pathway	5/81	0.02884489733886679	0.21757293992745236	0	0	3.0618012812460744	10.856602864221621	LYN;LILRB1;LILRB2;PIK3AP1;LILRA4
Influenza A	8/172	0.030598409481526177	0.2243883361978586	0	0	2.276266416510319	7.936902241976963	HLA-DMA;IRF3;HLA-DPB1;HLA-DRA;HLA-DOA;HLA-DRB1;HLA-DPA1;HLA-DQB1
Fructose and mannose metabolism	3/33	0.032265124879428224	0.23021602616673112	0	0	4.6427553444180525	15.942146391752466	HKDC1;ALDOC;GFUS
Glutamatergic synapse	6/114	0.03456287325635239	0.23723300713887227	0	0	2.587453482190324	8.706716799493668	HOMER1;GNAQ;PLA2G4B;TRPC1;GNB4;GRIK4
Pathways in cancer	18/531	0.03504578514551522	0.23723300713887227	0	0	1.647480770892749	5.52087268836554	GSTM3;NOTCH3;CDKN2B;ARHGEF12;DAPK1;FLT3;ITGA3;PLEKHG5;VEGFB;FLT3LG;RXRB;CCND2;PAX8;GNAQ;CDK2;COL4A3;GNB4;JAK3
ECM-receptor interaction	5/88	0.03919682365361012	0.2586990361138268	0	0	2.8025706645196538	9.077973573764044	TNXB;ITGA3;COL6A2;COL4A3;CD36
Sphingolipid signaling pathway	6/119	0.04125801396098078	0.26477663296714493	0	0	2.4723292543506794	7.881562923876579	CERS5;PDPK1;GNAQ;ADORA1;MS4A2;MAP3K5
AMPK signaling pathway	6/120	0.04268843812201586	0.26477663296714493	0	0	2.4505162427600102	7.728504695642467	SREBF1;CPT1A;PDPK1;INSR;CD36;CPT1B
Endocytosis	10/252	0.04312649703631527	0.26477663296714493	0	0	1.9297720285862578	6.066465487401647	ACAP3;PARD6B;ACAP1;GBF1;HLA-B;HLA-A;HLA-F;AP2A2;RAB11FIP4;ARFGAP1
GnRH secretion	4/64	0.04680450151395988	0.2808270090837593	0	0	3.097777777777778	9.484701326481868	CACNA1I;GABBR1;TRPC1;GNAQ
Cellular senescence	7/156	0.048837254735616016	0.28651189444894726	0	0	2.188675904913653	6.608185641286342	CDKN2B;RAD50;CCND2;CDK2;HLA-B;HLA-A;HLA-F
Human papillomavirus infection	12/331	0.05070401436343887	0.29099695199886655	0	0	1.7582554706759594	5.242678588597797	NOTCH3;PARD6B;TNXB;CCND2;IRF3;ITGA3;COL6A2;COL4A3;CDK2;HLA-B;HLA-A;HLA-F
Glycolysis / Gluconeogenesis	4/67	0.05379052632674488	0.3021425308566095	0	0	2.9498110355253213	8.621288579290168	LDHB;HKDC1;ALDOC;ENO2
Fc gamma R-mediated phagocytosis	5/97	0.05545232002968068	0.30498776016324375	0	0	2.527238767251219	7.309360141898744	LYN;FCGR3B;PLA2G4B;LIMK2;DOCK1
Adipocytokine signaling pathway	4/69	0.05874452503208103	0.3130668827870406	0	0	2.8587545787545787	8.103303720847785	RXRB;CPT1A;CD36;CPT1B
FoxO signaling pathway	6/131	0.06047882962931466	0.3130668827870406	0	0	2.2336076555023925	6.266301174078983	CDKN2B;CCND2;HOMER1;PDPK1;INSR;CDK2
Natural killer cell mediated cytotoxicity	6/131	0.06047882962931466	0.3130668827870406	0	0	2.2336076555023925	6.266301174078983	ZAP70;FCGR3B;LCK;HLA-B;HLA-A;MICA
Vascular smooth muscle contraction	6/133	0.06412258199997839	0.3255454163075826	0	0	2.1982066834947065	6.038382938023597	CALCRL;ARHGEF12;NPR2;GNAQ;PLA2G4B;MYL9
Non-small cell lung cancer	4/72	0.06661495212680475	0.32676476644868907	0	0	2.7322128851540617	7.40108990254221	RXRB;PDPK1;JAK3;FHIT
Tight junction	7/169	0.06891225666220048	0.32676476644868907	0	0	2.0116943482251237	5.381123912664195	PARD6B;CLDN15;RAPGEF2;F11R;MYL9;MAP3K5;TJP2
T cell receptor signaling pathway	5/104	0.07041532217007114	0.32676476644868907	0	0	2.3477013572478964	6.229260237476864	ZAP70;PDPK1;LCK;CD3E;CD3D
Autophagy	6/137	0.07178922899251503	0.32676476644868907	0	0	2.1306475766098103	5.612170094371821	DAPK1;CTSL;PDPK1;WDR41;ULK2;CTSB
Insulin signaling pathway	6/137	0.07178922899251503	0.32676476644868907	0	0	2.1306475766098103	5.612170094371821	SOCS2;SREBF1;PDPK1;PPP1R3E;INSR;HKDC1
Yersinia infection	6/137	0.07178922899251503	0.32676476644868907	0	0	2.1306475766098103	5.612170094371821	ZAP70;ARHGEF12;IRF3;LCK;GNAQ;DOCK1
Type II diabetes mellitus	3/46	0.07359710437067103	0.32810299581482083	0	0	3.2369772965806773	8.445758008259999	SOCS2;INSR;HKDC1
Thyroid hormone synthesis	4/75	0.07500374397937326	0.32810299581482083	0	0	2.6163648558014754	6.77695337385478	PAX8;ATF6B;GNAQ;TTF2
Measles	6/139	0.07581167706327299	0.32810299581482083	0	0	2.098391912796345	5.412808123505506	CCND2;IRF3;CDK2;CD3E;CD3D;JAK3
Amino sugar and nucleotide sugar metabolism	3/48	0.08135528440882743	0.34501118686259896	0	0	3.092794932699921	7.75960440852927	HKDC1;NPL;GFUS
HIF-1 signaling pathway	5/109	0.08233221504675657	0.34501118686259896	0	0	2.234257389388654	5.578924644907851	LDHB;INSR;HKDC1;ALDOC;ENO2
Renin-angiotensin system	2/23	0.08470070956228237	0.3493904269444148	0	0	4.413225005642067	10.894625382872945	NLN;MME
NOD-like receptor signaling pathway	7/181	0.09124854430641556	0.3703456969284704	0	0	1.8717991124341906	4.481401985626607	RNF31;IRF3;DEFA4;NAMPT;DEFA3;DEFA1;CTSB
Serotonergic synapse	5/113	0.0925864242321176	0.3703456969284704	0	0	2.1510651462918764	5.118702058182871	GNAQ;PLA2G4B;TRPC1;ALOX5;GNB4
Neomycin, kanamycin and gentamicin biosynthesis	1/5	0.10160929055542302	0.40037093591987577	0	0	11.567375886524824	26.45019658398454	HKDC1
Human cytomegalovirus infection	8/225	0.10701314501263312	0.41546279828434035	0	0	1.7156150301311592	3.834062648091002	ARHGEF12;IRF3;ATF6B;GNAQ;HLA-B;GNB4;HLA-A;HLA-F
Kaposi sarcoma-associated herpesvirus infection	7/193	0.11718193056155787	0.44546519514393024	0	0	1.7499548748098295	3.7519515325349095	LYN;IRF3;HLA-B;GNB4;HLA-A;HLA-F;MICA
Ribosome	6/158	0.12015654121570365	0.44546519514393024	0	0	1.834298665323596	3.8868052727939824	RPS9;RPL18A;RPS18;RPL18;RPL9;RPS12
PD-L1 expression and PD-1 checkpoint pathway in cancer	4/89	0.12058054928372462	0.44546519514393024	0	0	2.1838655462184873	4.619830614093038	ZAP70;LCK;CD3E;CD3D
Ras signaling pathway	8/232	0.12149050776652644	0.44546519514393024	0	0	1.661401098901099	3.502099183286042	ZAP70;FLT3;INSR;PLA2G4B;VEGFB;GNB4;FLT3LG;RGL2
Notch signaling pathway	3/59	0.1296373610257738	0.46882552480553813	0	0	2.483881913810655	5.074606162839833	NOTCH3;TLE2;PSEN2
Osteoclast differentiation	5/127	0.13324332536037675	0.4732399116990269	0	0	1.902852224265425	3.8353476671200912	FCGR3B;LCK;LILRB1;LILRB2;LILRA4
Long-term depression	3/60	0.1344431567326781	0.4732399116990269	0	0	2.4401800225028127	4.8964988973771115	LYN;PLA2G4B;GNAQ
Arachidonic acid metabolism	3/61	0.1393097044850643	0.48391792084285495	0	0	2.397985092964207	4.726562268833527	PLA2G4B;ALOX5;CYP4F3
cGMP-PKG signaling pathway	6/167	0.14481945497201887	0.4965238456183504	0	0	1.7309578293559986	3.3446734718771713	ATF6B;NPR2;INSR;GNAQ;ADORA1;MYL9
Aldosterone synthesis and secretion	4/98	0.15484043637960743	0.5240753231309789	0	0	1.9738601823708206	3.6819600962883254	NR4A2;CACNA1I;ATF6B;GNAQ
Cortisol synthesis and secretion	3/65	0.1593430126470887	0.5270004269872605	0	0	2.242816642402881	4.119372553590282	CACNA1I;ATF6B;GNAQ
Rap1 signaling pathway	7/210	0.15969709908704863	0.5270004269872605	0	0	1.602001157694534	2.9388332984463212	DOCK4;PARD6B;INSR;GNAQ;VEGFB;RAPGEF2;SIPA1L2
Nicotinate and nicotinamide metabolism	2/35	0.16944029047493112	0.5502773435795137	0	0	2.8066925175929915	4.982594035057063	NAPRT;NAMPT
MAPK signaling pathway	9/294	0.17411684144678813	0.5502773435795137	0	0	1.4679264426125556	2.5659775549288883	CACNA1I;FLT3;INSR;PLA2G4B;VEGFB;MAP3K20;FLT3LG;RAPGEF2;MAP3K5
Protein digestion and absorption	4/103	0.17527923488058708	0.5502773435795137	0	0	1.8736892736892736	3.2627955630961925	COL17A1;MME;COL6A2;COL4A3
Mucin type O-glycan biosynthesis	2/36	0.1770355696181978	0.5502773435795137	0	0	2.724003345413995	4.716351945282085	GCNT1;POC1B-GALNT4
Renin secretion	3/69	0.18018728846885948	0.5502773435795137	0	0	2.106456488879292	3.6099576653741137	GNAQ;ADORA1;CTSB
Apoptosis	5/142	0.18407162549984263	0.5502773435795137	0	0	1.6932041879344286	2.8656301193224283	CTSL;PDPK1;MAP3K5;BOK;CTSB
Aldosterone-regulated sodium reabsorption	2/37	0.18468272045659942	0.5502773435795137	0	0	2.646039268788084	4.469467135355744	PDPK1;INSR
Thyroid cancer	2/37	0.18468272045659942	0.5502773435795137	0	0	2.646039268788084	4.469467135355744	RXRB;PAX8
Central carbon metabolism in cancer	3/70	0.18551016507036638	0.5502773435795137	0	0	2.0749104832133867	3.495488816381294	LDHB;FLT3;HKDC1
Parathyroid hormone synthesis, secretion and action	4/106	0.18796220768471364	0.5513558092084933	0	0	1.8183006535947712	3.039315652033075	NR4A2;RXRB;ATF6B;GNAQ
Glucagon signaling pathway	4/107	0.19225417571277287	0.5577483778920004	0	0	1.8005547850208043	2.9690013166180504	LDHB;CPT1A;GNAQ;CPT1B
Homologous recombination	2/41	0.21568129607999684	0.6189115452730344	0	0	2.3741645400413174	3.6418578680784846	RAD50;XRCC3
Gastric acid secretion	3/76	0.21823743152081307	0.6195127088332758	0	0	1.9037842059024501	2.8978863905941195	KCNK10;GNAQ;SLC4A2
Coronavirus disease	7/232	0.2233697176094302	0.6273362281796763	0	0	1.4437196909139356	2.164030358536975	RPS9;RPL18A;IRF3;RPS18;RPL18;RPL9;RPS12
Fat digestion and absorption	2/43	0.23135615683675845	0.6331273668201418	0	0	2.258120448503063	3.305429828260263	CD36;AGPAT1
Fatty acid degradation	2/43	0.23135615683675845	0.6331273668201418	0	0	2.258120448503063	3.305429828260263	CPT1A;CPT1B
Cushing syndrome	5/155	0.23293057139197562	0.6331273668201418	0	0	1.545425616547335	2.25170806774726	CACNA1I;CDKN2B;ATF6B;GNAQ;CDK2
RNA degradation	3/79	0.23502455283474963	0.6331273668201418	0	0	1.828353544193024	2.6475753054645894	CNOT6;ENO2;EXOSC3
Vasopressin-regulated water reabsorption	2/44	0.23922122802626078	0.6379232747366954	0	0	2.204242834574588	3.1528751413149703	NSF;AQP3
Non-homologous end-joining	1/13	0.24319315706263403	0.6420299346453539	0	0	3.854215918045705	5.449473058933139	RAD50
Thyroid hormone signaling pathway	4/121	0.25512107423751124	0.6668511247396334	0	0	1.583964183964184	2.1637220748747215	RXRB;NOTCH3;PDPK1;PLCD1
Other types of O-glycan biosynthesis	2/47	0.26287668458889585	0.6766541141290358	0	0	2.056977356503423	2.748266223493496	POMT1;POC1B-GALNT4
Shigellosis	7/246	0.2678535234088995	0.6766541141290358	0	0	1.358167022867062	1.7891337948940254	CAST;RNF31;IRF3;HKDC1;MYL9;DOCK1;PLCD1
Cell cycle	4/124	0.26912379539223014	0.6766541141290358	0	0	1.5441269841269842	2.026796063463324	CDKN2B;CCND2;CDK2;PKMYT1
Platelet activation	4/124	0.26912379539223014	0.6766541141290358	0	0	1.5441269841269842	2.026796063463324	LYN;ARHGEF12;GNAQ;PLA2G4B
Thiamine metabolism	1/15	0.2749627967433104	0.6848130032097542	0	0	3.303275920297197	4.264923872116905	ALPL
GABAergic synapse	3/89	0.2922943703410422	0.7155961728195345	0	0	1.6149257029221675	1.986348710120635	NSF;GABBR1;GNB4
Relaxin signaling pathway	4/129	0.2927438888807186	0.7155961728195345	0	0	1.4819809523809524	1.8205500994813033	ATF6B;COL4A3;GNB4;VEGFB
Morphine addiction	3/91	0.30389269155993415	0.7245404338569681	0	0	1.5780608939753833	1.8795977609034968	GABBR1;ADORA1;GNB4
Phenylalanine metabolism	1/17	0.30540180530604316	0.7245404338569681	0	0	2.8900709219858154	3.4279910800321587	MIF
Lipid and atherosclerosis	6/215	0.30574456112364046	0.7245404338569681	0	0	1.3301206474210756	1.5762000078045828	LYN;RXRB;IRF3;PDPK1;CD36;MAP3K5
Endocrine and other factor-regulated calcium reabsorption	2/53	0.31012526146150526	0.7245404338569681	0	0	1.814422451445033	2.1242876921874756	GNAQ;AP2A2
Glycosaminoglycan biosynthesis	2/53	0.31012526146150526	0.7245404338569681	0	0	1.814422451445033	2.1242876921874756	NDST1;CHST15
Regulation of actin cytoskeleton	6/218	0.31687280426270975	0.7338107046083805	0	0	1.3110950618398483	1.5067823376649685	ARHGEF12;ITGA3;LIMK2;MYL9;DOCK1;SSH1
Fatty acid biosynthesis	1/18	0.32013979129858144	0.7349296078506565	0	0	2.7199276873870115	3.097990919808182	HSD17B8
Regulation of lipolysis in adipocytes	2/55	0.3257607574082569	0.7413865513429295	0	0	1.745774836805866	1.9580471606161607	INSR;ADORA1
Glycosaminoglycan degradation	1/19	0.33456578801325715	0.7501446340115683	0	0	2.5686892566325192	2.8125137182954205	IDUA
Circadian entrainment	3/97	0.33876168258962025	0.7501446340115683	0	0	1.476878758781018	1.5986598478110912	CACNA1I;GNAQ;GNB4
Glycerophospholipid metabolism	3/98	0.34456972101269684	0.7501446340115683	0	0	1.461257657207151	1.5569098676454434	GPD2;PLA2G4B;AGPAT1
One carbon pool by folate	1/20	0.3486863847142679	0.7501446340115683	0	0	2.433370660694289	2.5637564324223114	MTHFD2
AGE-RAGE signaling pathway in diabetic complications	3/100	0.3561713146662769	0.7501446340115683	0	0	1.430981707765017	1.477264582931217	COL4A3;VEGFB;PLCD1
Progesterone-mediated oocyte maturation	3/100	0.3561713146662769	0.7501446340115683	0	0	1.430981707765017	1.477264582931217	CDK2;PKMYT1;CPEB4
Signaling pathways regulating pluripotency of stem cells	4/143	0.35992171615174545	0.7501446340115683	0	0	1.3317574511819117	1.3608812903968646	SMAD1;PCGF3;COMMD3-BMI1;JAK3
Spinocerebellar ataxia	4/143	0.35992171615174545	0.7501446340115683	0	0	1.3317574511819117	1.3608812903968646	PSMB3;GNAQ;ULK2;MAP3K5
Herpes simplex virus 1 infection	12/498	0.3668007764206895	0.7501446340115683	0	0	1.1440728754644611	1.1474323560663466	HLA-DMA;IRF3;ZNF417;HLA-DPB1;HLA-B;HLA-DRA;HLA-A;HLA-DOA;HLA-F;HLA-DRB1;HLA-DPA1;HLA-DQB1
Chagas disease	3/102	0.3677455847770084	0.7501446340115683	0	0	1.4019290290074138	1.4024392268949974	GNAQ;CD3E;CD3D
Longevity regulating pathway	3/102	0.3677455847770084	0.7501446340115683	0	0	1.4019290290074138	1.4024392268949974	ATF6B;EHMT2;INSR
Pancreatic secretion	3/102	0.3677455847770084	0.7501446340115683	0	0	1.4019290290074138	1.4024392268949974	GNAQ;TRPC1;SLC4A2
Steroid hormone biosynthesis	2/61	0.37202351304760356	0.7501446340115683	0	0	1.5677564463009077	1.5501947828519265	CYP1B1;HSD17B8
Arginine biosynthesis	1/22	0.37603704365765206	0.7501446340115683	0	0	2.20139592480018	2.1531140730208316	GPT2
Terpenoid backbone biosynthesis	1/22	0.37603704365765206	0.7501446340115683	0	0	2.20139592480018	2.1531140730208316	ICMT
NF-kappa B signaling pathway	3/104	0.3792833086922934	0.7501446340115683	0	0	1.3740269513887255	1.3320804323925555	LYN;ZAP70;LCK
Alzheimer disease	9/369	0.38219625175199234	0.7501446340115683	0	0	1.1575903614457832	1.1133947818435719	BACE1;MME;PSMB3;INSR;GNAQ;PSEN2;ULK2;APBB1;MAP3K5
Phospholipase D signaling pathway	4/148	0.38398322168620685	0.7501446340115683	0	0	1.2851851851851852	1.2301232520127872	INSR;PLA2G4B;MS4A2;AGPAT1
Chemokine signaling pathway	5/192	0.38509912958050135	0.7501446340115683	0	0	1.2372851071433129	1.1806848793030216	LYN;GNAQ;GNB4;JAK3;CXCL5
Cytosolic DNA-sensing pathway	2/63	0.38717054223938474	0.7501446340115683	0	0	1.516199207520783	1.4387062742134973	IRF3;POLR2H
Mannose type O-glycan biosynthesis	1/23	0.3892796017408517	0.7501446340115683	0	0	2.101225016118633	1.9824163388787615	POMT1
Vitamin digestion and absorption	1/24	0.40224175710942606	0.7695059701223803	0	0	2.0097646212354814	1.8302966305021924	CUBN
Oxytocin signaling pathway	4/154	0.41270705343621195	0.7824383602363716	0	0	1.2333968253968255	1.0915774683189923	NPR2;GNAQ;PLA2G4B;MYL9
alpha-Linolenic acid metabolism	1/25	0.4149294334586819	0.7824383602363716	0	0	1.9259259259259258	1.6941346029466489	PLA2G4B
TNF signaling pathway	3/112	0.42489974804467495	0.7889509465812481	0	0	1.2726579354529408	1.089270503879213	ATF6B;CXCL5;MAP3K5
Folate biosynthesis	1/26	0.427348429398176	0.7889509465812481	0	0	1.8487943262411348	1.571762858185888	ALPL
Glycosylphosphatidylinositol (GPI)-anchor biosynthesis	1/26	0.427348429398176	0.7889509465812481	0	0	1.8487943262411348	1.571762858185888	PGAP1
Leukocyte transendothelial migration	3/114	0.43613177075827453	0.79348952821334	0	0	1.2495987674134943	1.0369306213250875	CLDN15;F11R;MYL9
Epithelial cell signaling in Helicobacter pylori infection	2/70	0.4388237542391956	0.79348952821334	0	0	1.359632004460552	1.1198709855434394	LYN;F11R
Prolactin signaling pathway	2/70	0.4388237542391956	0.79348952821334	0	0	1.359632004460552	1.1198709855434394	SOCS2;CCND2
Hepatitis B	4/162	0.450527157582889	0.8002197714860931	0	0	1.1704641350210971	0.9332542690294156	IRF3;ATF6B;CDK2;JAK3
JAK-STAT signaling pathway	4/162	0.450527157582889	0.8002197714860931	0	0	1.1704641350210971	0.9332542690294156	SOCS2;CCND2;IL11RA;JAK3
Inositol phosphate metabolism	2/73	0.46022850151020245	0.8002197714860931	0	0	1.301982511180829	1.010380314002081	ISYNA1;PLCD1
p53 signaling pathway	2/73	0.46022850151020245	0.8002197714860931	0	0	1.301982511180829	1.010380314002081	CCND2;CDK2
Linoleic acid metabolism	1/29	0.46304950478729145	0.8002197714860931	0	0	1.6504559270516717	1.27072118751331	PLA2G4B
Growth hormone synthesis, secretion and action	3/119	0.46383620352825233	0.8002197714860931	0	0	1.1954296011139323	0.9183574692651045	SOCS2;ATF6B;GNAQ
Neurotrophin signaling pathway	3/119	0.46383620352825233	0.8002197714860931	0	0	1.1954296011139323	0.9183574692651045	PDPK1;PSEN2;MAP3K5
Wnt signaling pathway	4/166	0.46915060426380695	0.8002197714860931	0	0	1.1413286302175192	0.863793395571259	TLE2;CCND2;DAAM1;SENP2
Huntington disease	7/306	0.47285144022667075	0.8002197714860931	0	0	1.0822566027445601	0.810582078085693	HIP1;PSMB3;GNAQ;ULK2;POLR2H;AP2A2;MAP3K5
Pentose phosphate pathway	1/30	0.4744493606761196	0.8002197714860931	0	0	1.5934621341811364	1.1880859856180082	ALDOC
Metabolism of xenobiotics by cytochrome P450	2/76	0.4811503047752631	0.8002197714860931	0	0	1.2490073011400025	0.9137432329482595	GSTM3;CYP1B1
Pertussis	2/76	0.4811503047752631	0.8002197714860931	0	0	1.2490073011400025	0.9137432329482595	IRF3;CXCL5
Galactose metabolism	1/31	0.4856077472634058	0.8002197714860931	0	0	1.54026792750197	1.112618829983172	HKDC1
RNA polymerase	1/31	0.4856077472634058	0.8002197714860931	0	0	1.54026792750197	1.112618829983172	POLR2H
Bacterial invasion of epithelial cells	2/77	0.4880128151865947	0.8002197714860931	0	0	1.2322906793048973	0.8840621083159943	SEPTIN1;DOCK1
Synaptic vesicle cycle	2/78	0.4948183504374161	0.8063706451572706	0	0	1.2160139685707159	0.855544323723962	NSF;AP2A2
Base excision repair	1/33	0.5072204165283611	0.8215103678741554	0	0	1.4438534278959811	0.980101601435063	POLE
Lysosome	3/128	0.5121154986200039	0.8233056042994265	0	0	1.1088456057007126	0.742045130167925	CTSL;IDUA;CTSB
Oocyte meiosis	3/129	0.5173386295468064	0.8233056042994265	0	0	1.0999886890623232	0.7249559378170147	CDK2;PKMYT1;CPEB4
Propanoate metabolism	1/34	0.517684584521609	0.8233056042994265	0	0	1.4000286553478043	0.9217636516927553	LDHB
Dopaminergic synapse	3/132	0.5328253180924086	0.8239311037771344	0	0	1.074241838369331	0.6763014556073819	ATF6B;GNAQ;GNB4
DNA replication	1/36	0.5379525238098228	0.8239311037771344	0	0	1.3198919284025667	0.8183131555496439	POLE
Starch and sucrose metabolism	1/36	0.5379525238098228	0.8239311037771344	0	0	1.3198919284025667	0.8183131555496439	HKDC1
Tyrosine metabolism	1/36	0.5379525238098228	0.8239311037771344	0	0	1.3198919284025667	0.8183131555496439	MIF
Insulin secretion	2/86	0.5471416571888036	0.8239311037771344	0	0	1.0997517490408486	0.6632025857619754	ATF6B;GNAQ
African trypanosomiasis	1/37	0.547765568169242	0.8239311037771344	0	0	1.2831625952193328	0.7723456759418039	GNAQ
Alanine, aspartate and glutamate metabolism	1/37	0.547765568169242	0.8239311037771344	0	0	1.2831625952193328	0.7723456759418039	GPT2
Apelin signaling pathway	3/137	0.5580023554880041	0.8239311037771344	0	0	1.0338922962385224	0.6031645930223606	NOTCH3;GNAQ;GNB4
Estrogen signaling pathway	3/137	0.5580023554880041	0.8239311037771344	0	0	1.0338922962385224	0.6031645930223606	GABBR1;ATF6B;GNAQ
Various types of N-glycan biosynthesis	1/39	0.5667722603223996	0.8239311037771344	0	0	1.2155032972502178	0.6901599925900372	ALG14
Fluid shear stress and atherosclerosis	3/139	0.5678426702803647	0.8239311037771344	0	0	1.018583205253598	0.5764273257515341	GSTM3;CTSL;MAP3K5
Glycine, serine and threonine metabolism	1/40	0.5759746067986985	0.8239311037771344	0	0	1.18427592895678	0.6533552060540595	ALAS2
Bladder cancer	1/41	0.5849819334588003	0.8239311037771344	0	0	1.154609929078014	0.6190721880506573	DAPK1
Ferroptosis	1/41	0.5849819334588003	0.8239311037771344	0	0	1.154609929078014	0.6190721880506573	SLC7A11
GnRH signaling pathway	2/93	0.5897238405312628	0.8239311037771344	0	0	1.014790896307484	0.5359120044822901	PLA2G4B;GNAQ
Salivary secretion	2/93	0.5897238405312628	0.8239311037771344	0	0	1.014790896307484	0.5359120044822901	GNAQ;SLC4A2
Tryptophan metabolism	1/42	0.5937983635317077	0.8239311037771344	0	0	1.126391051144554	0.5870924440336799	CYP1B1
IL-17 signaling pathway	2/94	0.5955586220457206	0.8239311037771344	0	0	1.0037090459509581	0.520177686600057	LCN2;CXCL5
TGF-beta signaling pathway	2/94	0.5955586220457206	0.8239311037771344	0	0	1.0037090459509581	0.520177686600057	SMAD1;CDKN2B
Porphyrin and chlorophyll metabolism	1/43	0.6024279335854577	0.8239311037771344	0	0	1.0995159293031633	0.5572206355364543	ALAS2
Prostate cancer	2/97	0.6126893284368669	0.8239311037771344	0	0	0.9718633075579945	0.4761131876731703	PDPK1;CDK2
Gastric cancer	3/149	0.6149730412474573	0.8239311037771344	0	0	0.948329157583054	0.4610556802321341	RXRB;CDKN2B;CDK2
Choline metabolism in cancer	2/98	0.6182751493330608	0.8239311037771344	0	0	0.9616903633491312	0.46240159071481857	PDPK1;PLA2G4B
Inflammatory mediator regulation of TRP channels	2/98	0.6182751493330608	0.8239311037771344	0	0	0.9616903633491312	0.46240159071481857	GNAQ;PLA2G4B
ABC transporters	1/45	0.6191422149405776	0.8239311037771344	0	0	1.04943047496239	0.5031182554902673	ABCB6
Glycosphingolipid biosynthesis	1/45	0.6191422149405776	0.8239311037771344	0	0	1.04943047496239	0.5031182554902673	B3GNT5
Diabetic cardiomyopathy	4/203	0.6271887617633317	0.8239311037771344	0	0	0.9273510409188801	0.4326164273554013	INSR;PDK4;CD36;CPT1B
Proteasome	1/46	0.6272345803995878	0.8239311037771344	0	0	1.0260572629366955	0.47858868791890313	PSMB3
Carbohydrate digestion and absorption	1/47	0.6351553976125465	0.8239311037771344	0	0	1.0037002775208141	0.4555650920223802	HKDC1
Nucleotide excision repair	1/47	0.6351553976125465	0.8239311037771344	0	0	1.0037002775208141	0.4555650920223802	POLE
Pyruvate metabolism	1/47	0.6351553976125465	0.8239311037771344	0	0	1.0037002775208141	0.4555650920223802	LDHB
mTOR signaling pathway	3/154	0.6372021909378018	0.8239311037771344	0	0	0.9166915732016171	0.4131237986063361	PDPK1;INSR;ULK2
Amoebiasis	2/102	0.6399989328699385	0.8239311037771344	0	0	0.9230331753554503	0.4119393405175288	GNAQ;COL4A3
Non-alcoholic fatty liver disease	3/155	0.641539019976038	0.8239311037771344	0	0	0.910613826728341	0.40420806491218914	SREBF1;INSR;MAP3K5
Hepatitis C	3/157	0.6501030773290869	0.8239311037771344	0	0	0.8986951290989296	0.3870000041616487	CLDN15;IRF3;CDK2
C-type lectin receptor signaling pathway	2/104	0.6504912808102449	0.8239311037771344	0	0	0.904841557476071	0.3891066487526765	ARHGEF12;CLEC7A
Cocaine addiction	1/49	0.6504968233712418	0.8239311037771344	0	0	0.9617809298660362	0.4135839432685635	ATF6B
Ether lipid metabolism	1/49	0.6504968233712418	0.8239311037771344	0	0	0.9617809298660362	0.4135839432685635	PLA2G4B
Sphingolipid metabolism	1/49	0.6504968233712418	0.8239311037771344	0	0	0.9617809298660362	0.4135839432685635	CERS5
Cholesterol metabolism	1/50	0.6579244601931852	0.8239311037771344	0	0	0.9421045013750181	0.39442632839928443	CD36
Cysteine and methionine metabolism	1/50	0.6579244601931852	0.8239311037771344	0	0	0.9421045013750181	0.39442632839928443	LDHB
Malaria	1/50	0.6579244601931852	0.8239311037771344	0	0	0.9421045013750181	0.39442632839928443	CD36
N-Glycan biosynthesis	1/50	0.6579244601931852	0.8239311037771344	0	0	0.9421045013750181	0.39442632839928443	ALG14
Vibrio cholerae infection	1/50	0.6579244601931852	0.8239311037771344	0	0	0.9421045013750181	0.39442632839928443	TJP2
Necroptosis	3/159	0.6585206927915733	0.8239311037771344	0	0	0.8870820391010414	0.37058680199973804	RNF31;PLA2G4B;JAK3
Drug metabolism	2/108	0.6707452753874277	0.8352677014258533	0	0	0.8705177501564876	0.34765504684771903	GSTM3;CES1
Hippo signaling pathway	3/163	0.6749158940159514	0.8365154742732919	0	0	0.8647268408551069	0.33998222847577403	SMAD1;PARD6B;CCND2
Pathways of neurodegeneration	9/475	0.6802305489548037	0.8391629202059261	0	0	0.8893427788406846	0.34268466841252065	HIP1;UBA7;PSMB3;GNAQ;WDR41;SEPTIN5;PSEN2;ULK2;MAP3K5
Fanconi anemia pathway	1/54	0.6860930880971374	0.8424584895704386	0	0	0.8708238547660466	0.3280758889312735	FANCD2
Cholinergic synapse	2/113	0.694715376270017	0.8490965709966876	0	0	0.8310917552623713	0.30272770489285317	GNAQ;GNB4
Hedgehog signaling pathway	1/56	0.6992971965139354	0.8507578796298569	0	0	0.8390715667311412	0.3001186592423214	CCND2
Glutathione metabolism	1/57	0.7056899660060846	0.85459702305324	0	0	0.8240459304289092	0.2872453367650114	GSTM3
Endometrial cancer	1/58	0.7119471417945842	0.8582376503825124	0	0	0.8095475094355273	0.27504506919913063	PDPK1
VEGF signaling pathway	1/59	0.7180715932235893	0.8616859118683071	0	0	0.7955490339936415	0.2634747046747399	PLA2G4B
Mineral absorption	1/60	0.724066129068569	0.8649477740909602	0	0	0.782025083143006	0.25249443453747344	TRPM6
Glycerolipid metabolism	1/61	0.729933498738947	0.8680290255273965	0	0	0.7689519306540583	0.2420674877220854	AGPAT1
Lysine degradation	1/63	0.741297448484405	0.8696822464048559	0	0	0.744070769465416	0.22274005461331586	EHMT2
Chemical carcinogenesis	4/239	0.7489364774896492	0.8696822464048559	0	0	0.7838297872340425	0.22660606061677346	RXRB;GSTM3;ATF6B;CYP1B1
Calcium signaling pathway	4/240	0.7518347038883474	0.8696822464048559	0	0	0.7804681194511703	0.22261978035006366	CACNA1I;GNAQ;VEGFB;PLCD1
Cytokine-cytokine receptor interaction	5/295	0.7525051810942313	0.8696822464048559	0	0	0.79359723479549	0.2256573081453659	IL11RA;CD27;TNFRSF25;TNFRSF4;CXCL5
Aminoacyl-tRNA biosynthesis	1/66	0.7574550903626134	0.8696822464048559	0	0	0.7096199308965266	0.1971260515166399	VARS1
RNA transport	3/186	0.7579465580659926	0.8696822464048559	0	0	0.7551497215840505	0.20928400596957172	NUP85;SMN1;SENP2
Purine metabolism	2/129	0.7618642230775744	0.8696822464048559	0	0	0.7257902003955666	0.19740544415468297	NPR2;FHIT
Acute myeloid leukemia	1/67	0.7626140351342163	0.8696822464048559	0	0	0.6988322945769754	0.18938580724751786	FLT3
Long-term potentiation	1/67	0.7626140351342163	0.8696822464048559	0	0	0.6988322945769754	0.18938580724751786	GNAQ
Neutrophil extracellular trap formation	3/189	0.7674063782825568	0.8696822464048559	0	0	0.7428549536433989	0.19666252131678633	FCGR3B;CLEC7A;AZU1
Retinol metabolism	1/68	0.7676635013003388	0.8696822464048559	0	0	0.6883666772520377	0.18200675920012205	DHRS3
Amphetamine addiction	1/69	0.77260580671956	0.8696822464048559	0	0	0.6782088722013628	0.17496860635737735	ATF6B
Parkinson disease	4/249	0.7767721360551701	0.8696822464048559	0	0	0.7514480077745384	0.18982195329569132	UBA7;PSMB3;SEPTIN5;MAP3K5
RIG-I-like receptor signaling pathway	1/70	0.7774432202710077	0.8696822464048559	0	0	0.6683454962825915	0.16825241385844988	IRF3
Adherens junction	1/71	0.7821779629639142	0.8712868448205626	0	0	0.6587639311043566	0.1618405047937635	INSR
MicroRNAs in cancer	5/310	0.7894307536406457	0.8756710880719768	0	0	0.7539809851715639	0.1782736454054609	NOTCH3;TNXB;CCND2;CYP1B1;COMMD3-BMI1
Ubiquitin mediated proteolysis	2/140	0.8002713777068692	0.8839817728644914	0	0	0.6675595851363417	0.14873520395430742	UBA7;RHOBTB1
Arrhythmogenic right ventricular cardiomyopathy	1/77	0.808548917827274	0.8894038096100014	0	0	0.6065696155281821	0.12890459433647208	ITGA3
Proteoglycans in cancer	3/205	0.8128772379529913	0.8904547336912436	0	0	0.6834505303261917	0.14159398641151574	ARHGEF12;CTSL;PDPK1
Retrograde endocannabinoid signaling	2/148	0.8246566658079791	0.8996254536087045	0	0	0.6307212880607674	0.12159558519724972	GNAQ;GNB4
Adrenergic signaling in cardiomyocytes	2/150	0.8303205512534398	0.902076648275342	0	0	0.6221339823235558	0.11568173680856252	ATF6B;GNAQ
cAMP signaling pathway	3/216	0.8395887582823376	0.9031607719498911	0	0	0.6477869592854036	0.11326106746815592	GABBR1;ADORA1;MYL9
Taste transduction	1/86	0.8422534044654847	0.9031607719498911	0	0	0.5420942845223196	0.0930636864253427	GABBR1
Cardiac muscle contraction	1/87	0.8456120384428318	0.9031607719498911	0	0	0.5357633734674804	0.08984462887207063	SLC9A7
Gap junction	1/88	0.8488993267067232	0.9031607719498911	0	0	0.5295780005978098	0.08675264984223545	GNAQ
Neuroactive ligand-receptor interaction	5/341	0.8520204934890246	0.9031607719498911	0	0	0.6833162859415842	0.10942948096891615	P2RY13;GABBR1;CALCRL;ADORA1;GRIK4
Bile secretion	1/90	0.8552658825283059	0.9031607719498911	0	0	0.5176242462878848	0.08092686783997115	SLC4A2
Hypertrophic cardiomyopathy	1/90	0.8552658825283059	0.9031607719498911	0	0	0.5176242462878848	0.08092686783997115	ITGA3
Thermogenesis	3/232	0.8725403382240557	0.9119631404333594	0	0	0.6020288562271158	0.0820844630602155	CPT1A;CPT1B;MAP3K5
Dilated cardiomyopathy	1/96	0.872804087917755	0.9119631404333594	0	0	0.48478287918377505	0.06595187996494614	ITGA3
Phosphatidylinositol signaling system	1/97	0.8755136089751042	0.9119631404333594	0	0	0.4797084318360914	0.06377463750161685	PLCD1
Protein processing in endoplasmic reticulum	2/171	0.880539396174708	0.9119631404333594	0	0	0.5442384811688494	0.06923835106375442	ATF6B;MAP3K5
Viral protein interaction with cytokine and cytokine receptor	1/100	0.8833015152833577	0.9119631404333594	0	0	0.4651001743200325	0.05771366193310543	CXCL5
Melanogenesis	1/101	0.8857879164156369	0.9119631404333594	0	0	0.4604255319148936	0.05583936289460772	GNAQ
Amyotrophic lateral sclerosis	5/364	0.8877822995885355	0.9119631404333594	0	0	0.638773841418419	0.07603243537538391	NUP85;PSMB3;WDR41;ULK2;MAP3K5
Toll-like receptor signaling pathway	1/104	0.8929344527982428	0.9137003703051787	0	0	0.4469462232321146	0.050613129764645194	IRF3
Alcoholism	2/186	0.9075946517802523	0.9251157840540023	0	0	0.4994848547290336	0.048428762244006454	ATF6B;GNB4
Pathogenic Escherichia coli infection	2/197	0.9236733566635782	0.9378837159968639	0	0	0.47104143881395066	0.03739917346212581	ARHGEF12;CLDN15
Breast cancer	1/147	0.9576397390718959	0.9686470923945615	0	0	0.3146151105929596	0.013617683091167461	NOTCH3
Hepatocellular carcinoma	1/168	0.9730857587562961	0.9805138943193211	0	0	0.2747554536317436	0.007496170126943808	GSTM3
Prion disease	2/273	0.9806469389413757	0.9843756345267041	0	0	0.3376121438939508	0.006597880980512622	ATF6B;PSMB3
Salmonella infection	1/249	0.9953400049745005	0.9953400049745005	0	0	0.18424464272096394	8.605858424077943E-4	MYL9
